Acorah Software Products - Accounts Production 16.5.460 false true 31 January 2024 1 February 2023 false 1 February 2024 31 January 2025 31 January 2025 08829405 Dr Alastair O'Brien Dr Laura Shallcross Mr Mark Richards true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08829405 2024-01-31 08829405 2025-01-31 08829405 2024-02-01 2025-01-31 08829405 frs-core:CurrentFinancialInstruments 2025-01-31 08829405 frs-core:ShareCapital 2025-01-31 08829405 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 08829405 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 08829405 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 08829405 frs-bus:SmallEntities 2024-02-01 2025-01-31 08829405 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 08829405 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 08829405 1 2024-02-01 2025-01-31 08829405 frs-bus:Director1 2024-02-01 2025-01-31 08829405 frs-bus:Director1 2024-01-31 08829405 frs-bus:Director1 2025-01-31 08829405 frs-bus:Director2 2024-02-01 2025-01-31 08829405 frs-bus:Director2 2024-01-31 08829405 frs-bus:Director2 2025-01-31 08829405 frs-bus:CompanySecretary1 2024-02-01 2025-01-31 08829405 frs-countries:EnglandWales 2024-02-01 2025-01-31 08829405 2023-01-31 08829405 2024-01-31 08829405 2023-02-01 2024-01-31 08829405 frs-core:CurrentFinancialInstruments 2024-01-31 08829405 frs-core:ShareCapital 2024-01-31 08829405 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31
Registered number: 08829405
Langdale Medical Limited
Unaudited Financial Statements
For The Year Ended 31 January 2025
Lloyd Richards Ltd
Eaton House Stoke Prior Lane
Leominster
Herefordshire
HR6 0NA
Langdale Medical Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2—3

Page 1
Langdale Medical Limited
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 08829405

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Debtors | 4 | 21,743 |  | 28,214 |
Cash at bank and in hand |  | 68 |  | 7,380 |
|  | 21,811 |  | 35,594 |
Creditors: Amounts Falling Due Within One Year | 5 | (4,270 ) |  | (3,877 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 17,541 |  | 31,717
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 17,541 |  | 31,717
NET ASSETS |  |  | 17,541 |  | 31,717
CAPITAL AND RESERVES
Called up share capital | 6 |  | 100 |  | 100
Profit and Loss Account |  |  | 17,441 |  | 31,617
SHAREHOLDERS' FUNDS |  |  | 17,541 |  | 31,717

For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Alastair O'Brien Director
07/10/2025

The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Langdale Medical Limited
Notes to the Financial Statements
For The Year Ended 31 January 2025
Notes to the Financial Statements
1. General Information
Langdale Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08829405 . The registered office is Eaton House, Stoke Prior Lane, Leominster, Herefordshire, HR6 0NA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover comprises the invoiced value of services supplied by the company, which is not VAT registered.
2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year adjusted if necessary for disallowed expenses if appropriate. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised in the event of the net book value of assets exceeding their written down value for tax purposes at the balance sheet date at the current rate of Corporation Tax.
2.4. Pensions
The company operates a defined pension contribution scheme provided by B&CE Holdings ("People's Partnership").
Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
3. Average Number of Employees
Average number of employees, including directors, during the year was:

| 2025 |  | 2024
--- | --- | --- | ---
Sales, marketing and distribution | 2 |  | 2
| 2 |  | 2

4. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Directors' loan accounts | 21,743 |  | 28,214

5. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Corporation tax | 3,336 |  | 3,114
Accruals and deferred income | 934 |  | 763
| 4,270 |  | 3,877

6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 2
Page 3
Langdale Medical Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 January 2025
7. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:

| As at 1 February 2024 | Amounts advanced | Amounts repaid | Amounts written off | As at 31 January 2025
--- | --- | --- | --- | --- | ---
| £ | £ | £ | £ | £
Dr Alastair O'Brien | 14,069 | 10,875 | 14,069 | - | 10,875
Dr Laura Shallcross | 14,145 | 10,868 | 14,145 | - | 10,868

The above loan is unsecured, interest free and repayable on demand.
Dividends paid to directors

| 2025 | 2024
--- | --- | ---
| £ | £
Dr Alastair O'Brien | 14,200 | 7,500
Dr Laura Shallcross | 14,200 | 7,500

8. Dividends

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
On equity shares:
Final dividend paid | 28,400 |  | 15,000

9. Ultimate Controlling Party
The company's ultimate controlling party is the O'Brien family by virtue of their ownership of 100% of the issued share capital in the company.
Page 3